Michael Rinaldi

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Procedures

Microbial Sensitivity Tests

Disorders

Living Beings

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Sutton Deanna A; Wickes Brian L; Romanelli Anna M; Rinaldi Michael G; Thompson Elizabeth H; Fothergill Annette W; Dishop Megan K; Elidemir Okan; Mallory George B; Moonnamakal Siby P; Adesina Adekunle M; Schecter Marc G
Cerebral aspergillosis caused by Aspergillus granulosus.
Fothergill Annette W; Rinaldi Michael G; Sutton Deanna A
Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.
Brzankalski Gabriela E; Najvar Laura K; Wiederhold Nathan P; Bocanegra Rosie; Fothergill Annette W; Rinaldi Michael G; Pattterson Thomas F; Graybill John R
Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Michael Rinaldi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Sutton Deanna A; Wickes Brian L; Romanelli Anna M; Rinaldi Michael G; Thompson Elizabeth H; Fothergill Annette W; Dishop Megan K; Elidemir Okan; Mallory George B; Moonnamakal Siby P; Adesina Adekunle M; Schecter Marc G
Cerebral aspergillosis caused by Aspergillus granulosus.
Journal of clinical microbiology 2009;47(10):3386-90.
2009: Fothergill Annette W; Rinaldi Michael G; Sutton Deanna A
Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2009;47(1):41-3.
2008: Brzankalski Gabriela E; Najvar Laura K; Wiederhold Nathan P; Bocanegra Rosie; Fothergill Annette W; Rinaldi Michael G; Pattterson Thomas F; Graybill John R
Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.
The Journal of antimicrobial chemotherapy 2008;62(5):1094-100.
2008: Sutton D A; Wickes B L; Thompson E H; Rinaldi M G; Roland R M; Libal M C; Russell K; Gordon S
Pulmonary Phialemonium curvatum phaeohyphomycosis in a Standard Poodle dog.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2008;46(4):355-9.
2007: Pfaller M A; Diekema D J; Procop G W; Rinaldi M G
Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp.
Journal of clinical microbiology 2007;45(11):3522-8.
2007: Ferguson T D; Schniederjan S D; Dionne-Odom J; Brandt M E; Rinaldi M G; Nolte F S; Langston A; Zimmer S M
Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes.
Journal of clinical microbiology 2007;45(5):1648-51.
2007: Pfaller M A; Diekema D J; Procop G W; Rinaldi M G
Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp.
Journal of clinical microbiology 2007;45(3):796-802.
2006: Fothergill Annette W; Rinaldi Michael G; Sutton Deanna A
Antifungal susceptibility testing.
Infectious disease clinics of North America 2006;20(3):699-709.
2006: Pfaller M A; Diekema D J; Rex J H; Espinel-Ingroff A; Johnson E M; Andes D; Chaturvedi V; Ghannoum M A; Odds F C; Rinaldi M G; Sheehan D J; Troke P; Walsh T J; Warnock D W
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.
Journal of clinical microbiology 2006;44(3):819-26.
2005: Pfaller M A; Diekema D J; Rinaldi M G; Barnes R; Hu B; Veselov A V; Tiraboschi N; Nagy E; Gibbs D L
Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.
Journal of clinical microbiology 2005;43(12):5848-59.
2005: Kirkpatrick William R; Vallor Ana C; McAtee Robert K; Ryder Neil S; Fothergill Annette W; Rinaldi Michael G; Patterson Thomas F
Combination therapy with terbinafine and amphotericin B in a rabbit model of experimental invasive aspergillosis.
Antimicrobial agents and chemotherapy 2005;49(11):4751-3.
2005: González Gloria M; Fothergill Annette W; Sutton Deanna A; Rinaldi Michael G; Loebenberg David
In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2005;43(3):281-4.
2005: Al-Abdely H M; Alkhunaizi A M; Al-Tawfiq J A; Hassounah M; Rinaldi M G; Sutton D A
Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2005;43(1):91-5.
2005: Sutton D A; Thompson E H; Rinaldi M G; Iwen P C; Nakasone K K; Jung H S; Rosenblatt H M; Paul M E
Identification and first report of Inonotus (Phellinus) tropicalis as an etiologic agent in a patient with chronic granulomatous disease.
Journal of clinical microbiology 2005;43(2):982-7.
2004: Burn A K; Fothergill A W; Kirkpatrick W R; Coco B J; Patterson T F; McCarthy D I; Rinaldi M G; Redding S W
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
Journal of clinical microbiology 2004;42(12):5846-8.
2004: O'Donnell Kerry; Sutton Deanna A; Rinaldi Michael G; Magnon Karen C; Cox Patricia A; Revankar Sanjay G; Sanche Stephen; Geiser David M; Juba Jean H; van Burik Jo-Anne H; Padhye Arvind; Anaissie Elias J; Francesconi Andrea; Walsh Thomas J; Robinson Jody S
Genetic diversity of human pathogenic members of the Fusarium oxysporum complex inferred from multilocus DNA sequence data and amplified fragment length polymorphism analyses: evidence for the recent dispersion of a geographically widespread clonal lineage and nosocomial origin.
Journal of clinical microbiology 2004;42(11):5109-20.
2004: Revankar S G; Fu J; Rinaldi M G; Kelly S L; Kelly D E; Lamb D C; Keller S M; Wickes B L
Cloning and characterization of the lanosterol 14alpha-demethylase (ERG11) gene in Cryptococcus neoformans.
Biochemical and biophysical research communications 2004;324(2):719-28.
2004: Sutton D A; Rinaldi M G; Kielhofner M
First U.S. report of subcutaneous phaeohyphomycosis caused by Veronaea botryosa in a heart transplant recipient and review of the literature.
Journal of clinical microbiology 2004;42(6):2843-6.
2004: González Gloria M; Tijerina Rolando; Najvar Laura K; Bocanegra Rosie; Rinaldi Michael G; Graybill John R
Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis.
Antimicrobial agents and chemotherapy 2004;48(6):2140-3.
2004: Redding Spencer W; Dahiya Marta C; Kirkpatrick William R; Coco Brent J; Patterson Thomas F; Fothergill Annette W; Rinaldi Michael G; Thomas Charles R
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2004;97(1):47-52.
2003: Bossler A D; Richter S S; Chavez A J; Vogelgesang S A; Sutton D A; Grooters A M; Rinaldi M G; de Hoog G S; Pfaller M A
Exophiala oligosperma causing olecranon bursitis.
Journal of clinical microbiology 2003;41(10):4779-82.
2003: Dahiya Marta C; Redding Spencer W; Dahiya Rajiv S; Eng Tony Y; Kirkpatrick William R; Coco Brent J; Sadkowski Lee C; Fothergill A W; Waite Annette; Rinaldi Michael G; Patterson Thomas F; Thomas Charles R
Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer.
International journal of radiation oncology, biology, physics 2003;57(1):79-83.
2003: Porteous N B; Grooters A M; Redding S W; Thompson E H; Rinaldi M G; De Hoog G S; Sutton D A
Identification of Exophiala mesophila isolated from treated dental unit waterlines.
Journal of clinical microbiology 2003;41(8):3885-9.
2003: Pennick Gennethel J; Clark Martin; Sutton Deanna A; Rinaldi Michael G
Development and validation of a high-performance liquid chromatography assay for voriconazole.
Antimicrobial agents and chemotherapy 2003;47(7):2348-50.
2003: Manire Charles A; Rhinehart Howard L; Pennick Gennethel J; Sutton Deanna A; Hunter Robert P; Rinaldi Michael G
Steady-state plasma concentrations of itraconazole after oral administration in Kemp's ridley sea turtles, Lepidochelys kempi.
Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 2003;34(2):171-8.
2003: González Gloria M; Tijerina Rolando; Najvar Laura K; Bocanegra Rosie; Rinaldi Michael G; Loebenberg David; Graybill John R
Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays.
Antimicrobial agents and chemotherapy 2003;47(4):1436-8.
2002: Yildiran S T; Fothergill A W; Sutton D A; Rinaldi M G
In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole, voriconazole and posaconazole (SCH56592).
Mycoses 2002;45(9-10):378-83.
2002: Manire Charles A; Rhinehart Howard L; Sutton Deanna A; Thompson Elizabeth H; Rinaldi Michael G; Buck John D; Jacobson Elliott
Disseminated mycotic infection caused by Colletotrichum acutatum in a Kemp's ridley sea turtle (Lepidochelys kempi).
Journal of clinical microbiology 2002;40(11):4273-80.
2002: Espinel-Ingroff A; Fothergill A; Peter J; Rinaldi M G; Walsh T J
Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study.
Journal of clinical microbiology 2002;40(9):3204-8.
2002: Perea Sofia; Gonzalez Gloria; Fothergill Annette W; Kirkpatrick William R; Rinaldi Michael G; Patterson Thomas F
In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
Antimicrobial agents and chemotherapy 2002;46(9):3039-41.
2002: Redding Spencer W; Kirkpatrick William R; Coco Brent J; Sadkowski Lee; Fothergill Annette W; Rinaldi Michael G; Eng Tony Y; Patterson Thomas F
Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer.
Journal of clinical microbiology 2002;40(5):1879-81.
2002: Perea Sofia; Gonzalez Gloria; Fothergill Annette W; Sutton Deanna A; Rinaldi Michael G
In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles.
Journal of clinical microbiology 2002;40(5):1831-3.
2002: González Gloria M; Tijerina Rolando; Sutton Deanna A; Graybill John R; Rinaldi Michael G
In vitro activities of free and lipid formulations of amphotericin B and nystatin against clinical isolates of Coccidioides immitis at various saprobic stages.
Antimicrobial agents and chemotherapy 2002;46(5):1583-5.
2002: Sun Qiu N; Fothergill Annette W; McCarthy Dora I; Rinaldi Michael G; Graybill John R
In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes.
Antimicrobial agents and chemotherapy 2002;46(5):1581-2.
2001: Rex J H; Pfaller M A; Walsh T J; Chaturvedi V; Espinel-Ingroff A; Ghannoum M A; Gosey L L; Odds F C; Rinaldi M G; Sheehan D J; Warnock D W
Antifungal susceptibility testing: practical aspects and current challenges.
Clinical microbiology reviews 2001;14(4):643-58, table of contents.
2001: Blumberg H M; Jarvis W R; Soucie J M; Edwards J E; Patterson J E; Pfaller M A; Rangel-Frausto M S; Rinaldi M G; Saiman L; Wiblin R T; Wenzel R P;
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(2):177-86.
2001: Redding S W; Bailey C W; Lopez-Ribot J L; Kirkpatrick W R; Fothergill A W; Rinaldi M G; Patterson T F
Candida dubliniensis in radiation-induced oropharyngeal candidiasis.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2001;91(6):659-62.
2001: González G M; Tijerina R; Najvar L K; Bocanegra R; Luther M; Rinaldi M G; Graybill J R
Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model.
Antimicrobial agents and chemotherapy 2001;45(6):1854-9.
2001: González G M; Sutton D A; Thompson E; Tijerina R; Rinaldi M G
In vitro activities of approved and investigational antifungal agents against 44 clinical isolates of basidiomycetous fungi.
Antimicrobial agents and chemotherapy 2001;45(2):633-5.
2001: Perea S; Fothergill A W; Sutton D A; Rinaldi M G
Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method.
Journal of clinical microbiology 2001;39(1):385-8.
2000: Rinaldi M G
Dermatophytosis: epidemiological and microbiological update.
Journal of the American Academy of Dermatology 2000;43(5 Suppl):S120-4.
2000: Kirkpatrick W R; McAtee R K; Fothergill A W; Rinaldi M G; Patterson T F
Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.
Antimicrobial agents and chemotherapy 2000;44(10):2865-8.
2000: Redding S W; Kirkpatrick W R; Dib O; Fothergill A W; Rinaldi M G; Patterson T F
The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients.
Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 2000;20(5):178-81.
2000: Perea S; Pennick G J; Modak A; Fothergill A W; Sutton D A; Sheehan D J; Rinaldi M G
Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma.
Antimicrobial agents and chemotherapy 2000;44(5):1209-13.
2000: Al-Abdely H M; Najvar L; Bocanegra R; Fothergill A; Loebenberg D; Rinaldi M G; Graybill J R
SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ("Ramichloridium mackenziei").
Antimicrobial agents and chemotherapy 2000;44(5):1159-62.
2000: Yildiran S T; Saracli M A; Fothergill A W; Rinaldi M G
In vitro susceptibility of environmental Cryptococcus neoformans variety neoformans isolates from Turkey to six antifungal agents, including SCH56592 and voriconazole.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(4):317-9.
2000: Patterson J E; Peters J; Calhoon J H; Levine S; Anzueto A; Al-Abdely H; Sanchez R; Patterson T F; Rech M; Jorgensen J H; Rinaldi M G; Sako E; Johnson S; Speeg V; Halff G A; Trinkle J K
Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients.
Transplant infectious disease : an official journal of the Transplantation Society 2000;2(1):22-8.
2000: Kirkpatrick W R; McAtee R K; Fothergill A W; Loebenberg D; Rinaldi M G; Patterson T F
Efficacy of SCH56592 in a rabbit model of invasive aspergillosis.
Antimicrobial agents and chemotherapy 2000;44(3):780-2.
1999: Redding S W; Zellars R C; Kirkpatrick W R; McAtee R K; Caceres M A; Fothergill A W; Lopez-Ribot J L; Bailey C W; Rinaldi M G; Patterson T F
Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer.
Journal of clinical microbiology 1999;37(12):3896-900.
1999: Lin A L; Shi Q; Johnson D A; Patterson T F; Rinaldi M G; Yeh C K
Further characterization of human salivary anticandidal activities in a human immunodeficiency virus-positive cohort by use of microassays.
Clinical and diagnostic laboratory immunology 1999;6(6):851-5.
1999: McGinnis M R; Sigler L; Rinaldi M G
Some medically important fungi and their common synonyms and names of uncertain application.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(4):728-30.
1999: Marco F; Lockhart S R; Pfaller M A; Pujol C; Rangel-Frausto M S; Wiblin T; Blumberg H M; Edwards J E; Jarvis W; Saiman L; Patterson J E; Rinaldi M G; Wenzel R P; Soll D R
Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3.
Journal of clinical microbiology 1999;37(9):2817-28.
1999: Lopez-Ribot J L; McAtee R K; Perea S; Kirkpatrick W R; Rinaldi M G; Patterson T F
Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients.
Antimicrobial agents and chemotherapy 1999;43(7):1621-30.
1999: Sutton D A; Sanche S E; Revankar S G; Fothergill A W; Rinaldi M G
In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.
Journal of clinical microbiology 1999;37(7):2343-5.
1999: Li R K; Rinaldi M G
In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole.
Antimicrobial agents and chemotherapy 1999;43(6):1401-5.
1999: Laurel V L; Meier P A; Astorga A; Dolan D; Brockett R; Rinaldi M G
Pseudoepidemic of Aspergillus niger infections traced to specimen contamination in the microbiology laboratory.
Journal of clinical microbiology 1999;37(5):1612-6.
1999: Sutton D A; Timm W D; Morgan-Jones G; Rinaldi M G
Human phaeohyphomycotic osteomyelitis caused by the coelomycete Phomopsis saccardo 1905: criteria for identification, case history, and therapy.
Journal of clinical microbiology 1999;37(3):807-11.
1999: Revankar S G; Sutton D A; Sanche S E; Rao J; Zervos M; Dashti F; Rinaldi M G
Metarrhizium anisopliae as a cause of sinusitis in immunocompetent hosts.
Journal of clinical microbiology 1999;37(1):195-8.
1998: Kirkpatrick W R; Turner T M; Fothergill A W; McCarthy D I; Redding S W; Rinaldi M G; Patterson T F
Fluconazole disk diffusion susceptibility testing of Candida species.
Journal of clinical microbiology 1998;36(11):3429-32.
1998: Kirkpatrick W R; Revankar S G; Mcatee R K; Lopez-Ribot J L; Fothergill A W; McCarthy D I; Sanche S E; Cantu R A; Rinaldi M G; Patterson T F
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Journal of clinical microbiology 1998;36(10):3007-12.
1998: McGinnis M R; Pasarell L; Sutton D A; Fothergill A W; Cooper C R; Rinaldi M G
In vitro activity of voriconazole against selected fungi.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36(4):239-42.
1998: Revankar S G; Kirkpatrick W R; McAtee R K; Dib O P; Fothergill A W; Redding S W; Rinaldi M G; Hilsenbeck S G; Patterson T F
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance.
The American journal of medicine 1998;105(1):7-11.
1998: Pfaller M A; Messer S A; Houston A; Rangel-Frausto M S; Wiblin T; Blumberg H M; Edwards J E; Jarvis W; Martin M A; Neu H C; Saiman L; Patterson J E; Dibb J C; Roldan C M; Rinaldi M G; Wenzel R P
National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species.
Diagnostic microbiology and infectious disease 1998;31(1):289-96.
1998: Kirkpatrick W R; McAtee R K; Revankar S G; Fothergill A W; McCarthy D I; Rinaldi M G; Patterson T F
Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans.
Journal of clinical microbiology 1998;36(5):1330-2.
1998: Revankar S G; Dib O P; Kirkpatrick W R; McAtee R K; Fothergill A W; Rinaldi M G; Redding S W; Patterson T F
Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(4):960-3.
1998: Sutton D A; Slifkin M; Yakulis R; Rinaldi M G
U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa.
Journal of clinical microbiology 1998;36(3):708-15.
1998: Odds F C; Van Gerven F; Espinel-Ingroff A; Bartlett M S; Ghannoum M A; Lancaster M V; Pfaller M A; Rex J H; Rinaldi M G; Walsh T J
Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.
Antimicrobial agents and chemotherapy 1998;42(2):282-8.
1998: Graybill J R; Najvar L K; Montalbo E M; Barchiesi F J; Luther M F; Rinaldi M G
Treatment of histoplasmosis with MK-991 (L-743,872).
Antimicrobial agents and chemotherapy 1998;42(1):151-3.
1998: Revankar S G; Kirkpatrick W R; McAtee R K; Fothergill A W; Redding S W; Rinaldi M G; Patterson T F
Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method.
Journal of clinical microbiology 1998;36(1):153-6.
1997: McGinnis M R; Pasarell L; Sutton D A; Fothergill A W; Cooper C R; Rinaldi M G
In vitro evaluation of voriconazole against some clinically important fungi.
Antimicrobial agents and chemotherapy 1997;41(8):1832-4.
1997: McGinnis M R; Rinaldi M G
Some medically important fungi and their common synonyms and obsolete names.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(1):15-7.
1997: Redding S W; Pfaller M A; Messer S A; Smith J A; Prows J; Bradley L L; Fothergill A W; Rinaldi M G
Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection.
Journal of clinical microbiology 1997;35(7):1761-5.
1997: Pfaller M A; Rex J H; Rinaldi M G
Antifungal susceptibility testing: technical advances and potential clinical applications.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(5):776-84.
1997: Sutton D A; Padhye A A; Standard P G; Rinaldi M G
An aberrant variant of Histoplasma capsulatum var. capsulatum.
Journal of clinical microbiology 1997;35(3):734-5.
1997: Rex J H; Pfaller M A; Galgiani J N; Bartlett M S; Espinel-Ingroff A; Ghannoum M A; Lancaster M; Odds F C; Rinaldi M G; Walsh T J; Barry A L
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(2):235-47.
1997: Odds F C; Rinaldi M G; Cooper C R; Fothergill A; Pasarell L; McGinnis M R
Candida and Torulopsis: a blinded evaluation of use of pseudohypha formation as basis for identification of medically important yeasts.
Journal of clinical microbiology 1997;35(1):313-6.
1997: Espinel-Ingroff A; Bartlett M; Bowden R; Chin N X; Cooper C; Fothergill A; McGinnis M R; Menezes P; Messer S A; Nelson P W; Odds F C; Pasarell L; Peter J; Pfaller M A; Rex J H; Rinaldi M G; Shankland G S; Walsh T J; Weitzman I
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.
Journal of clinical microbiology 1997;35(1):139-43.
1997: Rinaldi M G
Controversies in medical mycology.
Dermatology (Basel, Switzerland) 1997;194 Suppl 1():45-7.
1996: Patterson T F; Kirkpatrick W R; Revankar S G; McAtee R K; Fothergill A W; McCarthy D I; Rinaldi M G
Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans.
Journal of clinical microbiology 1996;34(12):3237-9.
1996: Revankar S G; Kirkpatrick W R; McAtee R K; Dib O P; Fothergill A W; Redding S W; Rinaldi M G; Patterson T F
Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients.
The Journal of infectious diseases 1996;174(4):821-7.
1996: Patterson T F; Peters J; Levine S M; Anzueto A; Bryan C L; Sako E Y; Miller O L; Calhoon J H; Rinaldi M G
Systemic availability of itraconazole in lung transplantation.
Antimicrobial agents and chemotherapy 1996;40(9):2217-20.
1996: Patterson T F; Revankar S G; Kirkpatrick W R; Dib O; Fothergill A W; Redding S W; Sutton D A; Rinaldi M G
Simple method for detecting fluconazole-resistant yeasts with chromogenic agar.
Journal of clinical microbiology 1996;34(7):1794-7.
1996: Dib J C; Dube M; Kelly C; Rinaldi M G; Patterson J E
Evaluation of pulsed-field gel electrophoresis as a typing system for Candida rugosa: comparison of karyotype and restriction fragment length polymorphisms.
Journal of clinical microbiology 1996;34(6):1494-6.
1996: Nguyen M H; Peacock J E; Morris A J; Tanner D C; Nguyen M L; Snydman D R; Wagener M M; Rinaldi M G; Yu V L
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
The American journal of medicine 1996;100(6):617-23.
1996: Barchiesi F; Najvar L K; Luther M F; Scalise G; Rinaldi M G; Graybill J R
Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model.
Antimicrobial agents and chemotherapy 1996;40(5):1317-20.
1996: Graybill J R; Bocanegra R; Fothergill A; Rinaldi M G
Bleomycin therapy of experimental disseminated candidiasis in mice.
Antimicrobial agents and chemotherapy 1996;40(3):816-8.
1996: Rinaldi M G
Epidemiology of mycoses in the HIV-infected patient: clinical aspects.
International journal of antimicrobial agents 1996;6(3):131-4.
1996: Rinaldi M G
Phaeohyphomycosis.
Dermatologic clinics 1996;14(1):147-53.
1995: Barchiesi F; Hollis R J; Messer S A; Scalise G; Rinaldi M G; Pfaller M A
Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients.
Diagnostic microbiology and infectious disease 1995;23(3):99-103.
1995: To W K; Fothergill A W; Rinaldi M G
Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
Journal of clinical microbiology 1995;33(10):2660-4.
1995: Barchiesi F; Hollis R J; Del Poeta M; McGough D A; Scalise G; Rinaldi M G; Pfaller M A
Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(3):561-4.
1995: McGinnis M R; Rinaldi M G
Selected medically important fungi and some common synonyms and obsolete names.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(2):277-8.
1995: Nguyen M H; Barchiesi F; McGough D A; Yu V L; Rinaldi M G
In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans.
Antimicrobial agents and chemotherapy 1995;39(8):1691-5.
1995: Colombo A L; Barchiesi F; McGough D A; Fothergill A W; Rinaldi M G
Evaluation of the E test system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole.
The Journal of antimicrobial chemotherapy 1995;36(1):93-100.
1995: Walsh T J; Peter J; McGough D A; Fothergill A W; Rinaldi M G; Pizzo P A
Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.
Antimicrobial agents and chemotherapy 1995;39(6):1361-4.
1995: Allendoerfer R; Loebenberg D; Rinaldi M G; Graybill J R
Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
Antimicrobial agents and chemotherapy 1995;39(6):1345-8.
1995: Pfaller M A; Bale M; Buschelman B; Lancaster M; Espinel-Ingroff A; Rex J H; Rinaldi M G; Cooper C R; McGinnis M R
Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.
Journal of clinical microbiology 1995;33(5):1104-7.
1995: Barchiesi F; Hollis R J; McGough D A; Scalise G; Rinaldi M G; Pfaller M A
DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(3):634-40.
1995: Colombo A L; Barchiesi F; McGough D A; Rinaldi M G
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing.
Journal of clinical microbiology 1995;33(3):535-40.
1995: Odds F C; Rinaldi M G
Nomenclature of fungal diseases.
Current topics in medical mycology 1995;6():33-46.
1994: Colombo A L; McGough D A; Rinaldi M G
Discrepancies between MIC and MLC values of amphotericin B against isolates of Aspergillus species.
Mycopathologia 1994;128(3):129-33.
1994: Barchiesi F; Colombo A L; McGough D A; Fothergill A W; Rinaldi M G
In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
Antimicrobial agents and chemotherapy 1994;38(11):2553-6.
1994: Barchiesi F; Colombo A L; McGough D A; Rinaldi M G
Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.
Journal of clinical microbiology 1994;32(10):2494-500.
1994: Barchiesi F; Colombo A L; McGough D A; Fothergill A W; Rinaldi M G
In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
Antimicrobial agents and chemotherapy 1994;38(7):1530-3.
1994: Pfaller M A; Bale M; Buschelman B; Lancaster M; Espinel-Ingroff A; Rex J H; Rinaldi M G
Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods.
Journal of clinical microbiology 1994;32(7):1650-3.
1994: Pfaller M A; Vu Q; Lancaster M; Espinel-Ingroff A; Fothergill A; Grant C; McGinnis M R; Pasarell L; Rinaldi M G; Steele-Moore L
Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.
Journal of clinical microbiology 1994;32(7):1625-8.
1994: Berenguer J; Ali N M; Allende M C; Lee J; Garrett K; Battaglia S; Piscitelli S C; Rinaldi M G; Pizzo P A; Walsh T J
Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma.
Antimicrobial agents and chemotherapy 1994;38(6):1303-8.
1994: Pfaller M A; Buschelman B; Bale M J; Lancaster M; Espinel-Ingroff A; Rex J H; Rinaldi M G
Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates.
Diagnostic microbiology and infectious disease 1994;19(1):9-13.
1994: Wallace J E; Mojaverian P; Lin C C; Kim H K; Harris S C; Chen T J; Rinaldi M G
Determination of SCH 39304 by megabore capillary gas-liquid chromatography.
Journal of analytical toxicology 1994;18(2):118-21.
1994: Pfaller M A; Rhine-Chalberg J; Redding S W; Smith J; Farinacci G; Fothergill A W; Rinaldi M G
Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis.
Journal of clinical microbiology 1994;32(1):59-64.
1994: Hostetler J S; Catanzaro A; Stevens D A; Graybill J R; Sharkey P K; Larsen R A; Tucker R M; al-Haidary A D; Rinaldi M G; Cloud G A
Treatment of coccidioidomycosis with SCH 39304.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1994;32(2):105-14.
1993: Velez J D; Allendoerfer R; Luther M; Rinaldi M G; Graybill J R
Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis.
The Journal of infectious diseases 1993;168(2):508-10.
1993: Pfaller M A; Rinaldi M G
Antifungal susceptibility testing. Current state of technology, limitations, and standardization.
Infectious disease clinics of North America 1993;7(2):435-44.
1993: Melcher G P; McGough D A; Fothergill A W; Norris C; Rinaldi M G
Disseminated hyalohyphomycosis caused by a novel human pathogen, Fusarium napiforme.
Journal of clinical microbiology 1993;31(6):1461-7.
1993: Rinaldi M G
Selected medically important fungi with common synonyms and other obsolete names.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;16(5):610-1.
1992: Hardin T C; Sharkey P K; Lam Y F; Wallace J E; Rinaldi M G; Graybill J R
Pharmacokinetics of SCH-39304 in human immunodeficiency virus-infected patients following chronic oral dosing.
Antimicrobial agents and chemotherapy 1992;36(12):2790-3.
1992: Salkin I F; Cooper C R; Bartges J W; Kemna M E; Rinaldi M G
Scedosporium inflatum osteomyelitis in a dog.
Journal of clinical microbiology 1992;30(11):2797-800.
1992: Pfaller M A; Dupont B; Kobayashi G S; Müller J; Rinaldi M G; Espinel-Ingroff A; Shadomy S; Troke P F; Walsh T J; Warnock D W
Standardized susceptibility testing of fluconazole: an international collaborative study.
Antimicrobial agents and chemotherapy 1992;36(9):1805-9.
1992: Wallace J E; Harris S C; Gallegos J; Foulds G; Chen T J; Rinaldi M G
Assay of fluconazole by high-performance liquid chromatography with a mixed-phase column.
Antimicrobial agents and chemotherapy 1992;36(3):603-6.
1992: Rinaldi M G
Laboratory evaluation of antifungal agents: a brief overview.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14 Suppl 1():S130-3.
1992: Redding S W; Farinacci G C; Smith J A; Fothergill A W; Rinaldi M G
A comparison between fluconazole tablets and clotrimazole troches for the treatment of thrush in HIV infection.
Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 1992;12(1):24-7.
1992: Allendoerfer R; Yates R R; Marquis A J; Loebenberg D; Rinaldi M G; Graybill J R
Comparison of SCH 39304 and its isomers, RR 42427 and SS 42426, for treatment of murine cryptococcal and coccidioidal meningitis.
Antimicrobial agents and chemotherapy 1992;36(1):217-9.
1992: Tucker R M; Denning D W; Hanson L H; Rinaldi M G; Graybill J R; Sharkey P K; Pappagianis D; Stevens D A
Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(1):165-74.
1992: Odds F C; Arai T; Disalvo A F; Evans E G; Hay R J; Randhawa H S; Rinaldi M G; Walsh T J
Nomenclature of fungal diseases: a report and recommendations from a Sub-Committee of the International Society for Human and Animal Mycology (ISHAM).
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1992;30(1):1-10.
1992: Dolan M J; Lattuada C P; Melcher G P; Zellmer R; Allendoerfer R; Rinaldi M G
Coccidioides immitis presenting as a mycelial pathogen with empyema and hydropneumothorax.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1992;30(3):249-55.
1991: Krajden S; Summerbell R C; Kane J; Salkin I F; Kemna M E; Rinaldi M G; Fuksa M; Spratt E; Rodriguez C;
Normally saprobic cryptococci isolated from Cryptococcus neoformans infections.
Journal of clinical microbiology 1991;29(9):1883-7.
1991: Allendoerfer R; Marquis A J; Rinaldi M G; Graybill J R
Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis.
Antimicrobial agents and chemotherapy 1991;35(4):726-9.
1991: Sharkey P K; Rinaldi M G; Dunn J F; Hardin T C; Fetchick R J; Graybill J R
High-dose itraconazole in the treatment of severe mycoses.
Antimicrobial agents and chemotherapy 1991;35(4):707-13.
1990: Lee J W; Melcher G A; Rinaldi M G; Pizzo P A; Walsh T J
Patterns of morphologic variation among isolates of Trichosporon beigelii.
Journal of clinical microbiology 1990;28(12):2823-7.
1990: Tucker R M; Denning D W; Arathoon E G; Rinaldi M G; Stevens D A
Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations.
Journal of the American Academy of Dermatology 1990;23(3 Pt 2):593-601.
1990: Sharkey P K; Graybill J R; Rinaldi M G; Stevens D A; Tucker R M; Peterie J D; Hoeprich P D; Greer D L; Frenkel L; Counts G W
Itraconazole treatment of phaeohyphomycosis.
Journal of the American Academy of Dermatology 1990;23(3 Pt 2):577-86.
1990: Walsh T J; Melcher G P; Rinaldi M G; Lecciones J; McGough D A; Kelly P; Lee J; Callender D; Rubin M; Pizzo P A
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B.
Journal of clinical microbiology 1990;28(7):1616-22.
1990: Walsh T J; Lester-McCully C; Rinaldi M G; Wallace J E; Balis F M; Lee J W; Pizzo P A; Poplack D G
Penetration of SCH-39304, a new antifungal triazole, into cerebrospinal fluid of primates.
Antimicrobial agents and chemotherapy 1990;34(6):1281-4.
1989: Harris S C; Wallace J E; Foulds G; Rinaldi M G
Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection.
Antimicrobial agents and chemotherapy 1989;33(5):714-6.
1989: Rinaldi M G
Emerging opportunists.
Infectious disease clinics of North America 1989;3(1):65-76.
1989: Rinaldi M G
Zygomycosis.
Infectious disease clinics of North America 1989;3(1):19-41.
1989: Maskin S L; Fetchick R J; Leone C R; Sharkey P K; Rinaldi M G
Bipolaris hawaiiensis-caused phaeohyphomycotic orbitopathy. A devastating fungal sinusitis in an apparently immunocompetent host.
Ophthalmology 1989;96(2):175-9.
1988: Hardin T C; Graybill J R; Fetchick R; Woestenborghs R; Rinaldi M G; Kuhn J G
Pharmacokinetics of itraconazole following oral administration to normal volunteers.
Antimicrobial agents and chemotherapy 1988;32(9):1310-3.
1988: Schwartz J G; McGough D A; Thorner R E; Fetchick R J; Tio F O; Rinaldi M G
Primary lymphocutaneous Nocardia brasiliensis infection: three case reports and a review of the literature.
Diagnostic microbiology and infectious disease 1988;10(2):113-20.
1988: Salkin I F; McGinnis M R; Dykstra M J; Rinaldi M G
Scedosporium inflatum, an emerging pathogen.
Journal of clinical microbiology 1988;26(3):498-503.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Michael Rinaldi

Research Profile (preview)

Chemicals & Drugs

Procedures

Disorders

Living Beings

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Michael Rinaldi (preview)

All Publications